Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it ...
Neuroscientist Matthew Sacchet is revealing how mastering meditation can not only enable transcendental states of bliss, but ...
Discover three strategies for MedTech companies to design streamlined, effective trials and how quality data powers smarter ...
Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...
The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.
Columbus Business First President & Publisher Nick Fortine speaks with experts from Trace3 and Cisco about how organizations ...
The company listed all of the systems that went haywire, but never really identified what happened differently that day to ...
A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...
The FDA’s clearance marks a significant regulatory milestone for Jupiter, enabling the Company to begin enrollment in its exploratory Phase 2a trial designed to evaluate the safety and tolerability of ...
Has zero trust lost its momentum—or are businesses just doing it wrong? In this episode of Today in Tech, host Keith Shaw sits down with Morey Haber, Chief Security Advisor at BeyondTrust and author ...
With greater understanding of the complex pathomechanisms of myalgic encephalomyelitis/chronic fatigue syndrome, researchers ...
A recent study has demonstrated that the TriClip™ transcatheter tricuspid repair system (Abbott) substantially lowered the severity of tricuspid regurgitation (TR) and quality of life in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback